Ing, Steven W. https://orcid.org/0000-0002-4343-6723
McDermott, Michele
Yeh, Eric
Lane, Joseph M.
Cheung, Jolenta
Amet, Mona
Binkley, Neil
Cosman, Felicia
Funding for this research was provided by:
Amgen
UCB Pharma
Article History
Received: 22 May 2025
Accepted: 10 March 2026
First Online: 25 March 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional or ethics committee approval of the protocol was obtained for both the qualitative and quantitative research.Informed consent: Patients completed a written informed consent form and HIPAA Authorization as part of the inclusion criteria.
: S. W. Ing received grant/research support paid to his institution from Alexion, Amolyt, Calcilytix, Radius, Takeda, and Ultragenyx and received consulting fees from Amgen, Ascendis, and Radius.M. McDermott is an employee and stockholder of Amgen.E. Yeh is an employee and stockholder of Amgen.J. M. Lane received grant/research support from Radius Health and Merck (either personally or through HSS); received consulting fees from Mesentech, Radius Health, Kuros, and BIC; was on the Global Advisory Board for UCB and Amgen; and was on the Scientific Advisory Board for Lenoss.J. Cheung is an employee of Adelphi Real World that received funding from Amgen for this work.M. Amet is an employee of Adelphi Real World that received funding from Amgen for this work.N. Binkley received grant/research support from Amgen, GE Healthcare, and Radius.F. Cosman received grant/research support from Amgen and Radius Health; received speaker fees from Amgen and Radius Health; and received consulting fees from Entera Bio, Amgen, UCB, Thermex, Biocon, and CuraTeQ.